NCT06496321 Morbidity of Conventional and No-touch Saphenectomy in Coronary Artery Bypass Grafting.
| NCT ID | NCT06496321 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto Nacional de Cirugia Cardiaca, Uruguay |
| Condition | Saphenectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2024-03-15 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2024-03-15 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A clinical research project will be carried out that will consist of a non-inferiority study. The objective is to compare the morbidity of two different surgical techniques for the extraction of the internal saphenous vein, intended to be used as a conduit in coronary bypass.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing coordination coronary revascularization surgery, in which it is necessary to use the internal saphenous vein as a conduit. Exclusion Criteria: * Emergency surgeries. * Poor metabolic control (HbA1c \> 6.5%). * Chronic venous insufficiency or chronic obstructive arteriopathy of the lower limbs. * Type II obesity (BMI\>35).
Contact & Investigator
Juan A Montero, MD
PRINCIPAL INVESTIGATOR
Instituto Nacional de Cirugía Cardíaca
Frequently Asked Questions
Who can join the NCT06496321 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Saphenectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06496321 currently recruiting?
Yes, NCT06496321 is actively recruiting participants. Contact the research team at juani.montero94@gmail.com for enrollment information.
Where is the NCT06496321 trial being conducted?
This trial is being conducted at Montevideo, Uruguay.
Who is sponsoring the NCT06496321 clinical trial?
NCT06496321 is sponsored by Instituto Nacional de Cirugia Cardiaca, Uruguay. The principal investigator is Juan A Montero, MD at Instituto Nacional de Cirugía Cardíaca. The trial plans to enroll 52 participants.